Literature DB >> 1379424

Immunogenicity of free synthetic peptides corresponding to T helper epitopes of the influenza HA 1 subunit. Induction of virus cross reacting CD4+ T lymphocytes in mice.

C Schneider1, M H Van Regenmortel.   

Abstract

Four linear synthetic peptides corresponding to residues 12-29, 50-67, 121-138 and 131-147 of the HA 1 subunit of H3 subtype influenza virus (NT/60/68) were tested for their capacity to elicit in vivo peptide-specific CD4+ T cells cross reacting with whole virus. By studying the in vitro peptide proliferative response of lymph node cells from mice sensitized in vivo with free peptides emulsified in complete or incomplete Freund adjuvant, it was found that region 12-29 could be recognized by CD4+ T lymphocytes in the context of H-2k and H-2b, region 50-67 in association with H-2b and region 121-138 in the context of H-2d MHC molecules. Outbred OF 1 mice could recognize regions 50-67 and 121-138. Peptides 50-67 and 121-138 are of potential interest for synthetic vaccine design since they induced in BALB/c (peptide 121-138) and OF 1 (both peptides) mice a CD4+ T cell population that cross reacted with whole virus. The region 50-67 is of particular interest since only few substitutions have been found in this area in natural variants of the H3 virus subtype.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1379424     DOI: 10.1007/bf01309631

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  32 in total

Review 1.  Chemical and functional analysis of MHC class II-restricted T cell epitopes.

Authors:  C Corradin; A Lanzavecchia
Journal:  Int Rev Immunol       Date:  1991       Impact factor: 5.311

2.  Antigenic properties and protective capacity of a cyclic peptide corresponding to site A of influenza virus haemagglutinin.

Authors:  S Muller; S Plaué; J P Samama; M Valette; J P Briand; M H Van Regenmortel
Journal:  Vaccine       Date:  1990-08       Impact factor: 3.641

3.  A single amino acid substitution in influenza hemagglutinin abrogates recognition by monoclonal antibody and a spectrum of subtype-specific L3T4+ T cell clones.

Authors:  D B Thomas; J J Skehel; K H Mills; C M Graham
Journal:  Eur J Immunol       Date:  1987-01       Impact factor: 5.532

4.  Class II-restricted T-cell clones to a synthetic peptide of influenza virus hemagglutinin differ in their fine specificities and in the ability to respond to virus.

Authors:  R A Ffrench; X L Tang; E M Anders; D C Jackson; D O White; H Drummer; J D Wade; G W Tregear; L E Brown
Journal:  J Virol       Date:  1989-07       Impact factor: 5.103

5.  The structural requirements for class II (I-Ad)-restricted T cell recognition of influenza hemagglutinin: B cell epitopes define T cell epitopes.

Authors:  C M Graham; B C Barnett; I Hartlmayr; D S Burt; R Faulkes; J J Skehel; D B Thomas
Journal:  Eur J Immunol       Date:  1989-03       Impact factor: 5.532

6.  Distinct epitopes recognized by I-Ad-restricted T-cell clones within antigenic site E on influenza virus hemagglutinin.

Authors:  L E Brown; R A Ffrench; J M Gawler; D C Jackson; M L Dyall-Smith; E M Anders; G W Tregear; L Duncan; P A Underwood; D O White
Journal:  J Virol       Date:  1988-01       Impact factor: 5.103

7.  Lymphocyte specificity to protein antigens. V. Conformational dependence of activation of cytochrome c-specific T cells.

Authors:  Y Buchmüller; G Corradin
Journal:  Eur J Immunol       Date:  1982-05       Impact factor: 5.532

8.  The recognition specificity of a murine helper T cell for hemagglutinin of influenza virus A/PR/8/34.

Authors:  W Gerhard; C Hackett; F Melchers
Journal:  J Immunol       Date:  1983-05       Impact factor: 5.422

9.  Influenza virus site recognized by a murine helper T cell specific for H1 strains. Localization to a nine amino acid sequence in the hemagglutinin molecule.

Authors:  C J Hackett; B Dietzschold; W Gerhard; B Ghrist; R Knorr; D Gillessen; F Melchers
Journal:  J Exp Med       Date:  1983-08-01       Impact factor: 14.307

10.  Functional analysis of influenza-specific helper T cell clones in vivo. T cells specific for internal viral proteins provide cognate help for B cell responses to hemagglutinin.

Authors:  P A Scherle; W Gerhard
Journal:  J Exp Med       Date:  1986-10-01       Impact factor: 14.307

View more
  5 in total

1.  Time for T?: Thoughts about the 2009 novel H1N1 influenza outbreak and the role of T cell epitopes in the next generation of influenza vaccines.

Authors:  Anne S De Groot; Elizabeth McClaine; Lenny Moise; William Martin
Journal:  Hum Vaccin       Date:  2010-02-19

2.  Coupling sensitive in vitro and in silico techniques to assess cross-reactive CD4(+) T cells against the swine-origin H1N1 influenza virus.

Authors:  Brian C Schanen; Anne S De Groot; L Moise; Matt Ardito; Elizabeth McClaine; William Martin; Vaughan Wittman; William L Warren; Donald R Drake
Journal:  Vaccine       Date:  2011-02-22       Impact factor: 3.641

3.  Immunogenicity of polysaccharides conjugated to peptides containing T- and B-cell epitopes.

Authors:  E Lett; S Gangloff; M Zimmermann; D Wachsmann; J P Klein
Journal:  Infect Immun       Date:  1994-03       Impact factor: 3.441

4.  Host adaptive immunity deficiency in severe pandemic influenza.

Authors:  Jesus F Bermejo-Martin; Ignacio Martin-Loeches; Jordi Rello; Andres Antón; Raquel Almansa; Luoling Xu; Guillermo Lopez-Campos; Tomás Pumarola; Longsi Ran; Paula Ramirez; David Banner; Derek Cheuk Ng; Lorenzo Socias; Ana Loza; David Andaluz; Enrique Maravi; Maria J Gómez-Sánchez; Mónica Gordón; Maria C Gallegos; Victoria Fernandez; Sara Aldunate; Cristobal León; Pedro Merino; Jesús Blanco; Fernando Martin-Sanchez; Lucia Rico; David Varillas; Veronica Iglesias; Maria Ángeles Marcos; Francisco Gandía; Felipe Bobillo; Begoña Nogueira; Silvia Rojo; Salvador Resino; Carmen Castro; Raul Ortiz de Lejarazu; David Kelvin
Journal:  Crit Care       Date:  2010-09-14       Impact factor: 9.097

5.  In Vivo Validation of Predicted and Conserved T Cell Epitopes in a Swine Influenza Model.

Authors:  Andres H Gutiérrez; Crystal Loving; Leonard Moise; Frances E Terry; Susan L Brockmeier; Holly R Hughes; William D Martin; Anne S De Groot
Journal:  PLoS One       Date:  2016-07-13       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.